The novel approach of tirzepatide peptide represents a significant advance in the care of the condition. Unlike existing drugs, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – leading to improved sugar control and anticipated weight loss. Experts are studying its long-term advanta